Peringatan Keamanan

Severe hypoglycemic reactions with coma, seizure, or other neurological impairment.

Glymidine

DB01382

small molecule approved investigational

Deskripsi

Glycodiazine is used with diet to lower blood glucose by increasing the secretion of insulin from pancreas and increasing the sensitivity of peripheral tissues to insulin. The mechanism of action of glycodiazine in lowering blood glucose appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells, and increasing sensitivity of peripheral tissues to insulin. Glycodiazine likely binds to ATP-sensitive potassium channel receptors on the pancreatic cell surface, reducing potassium conductance and causing depolarization of the membrane. Membrane depolarization stimulates calcium ion influx through voltage-sensitive calcium channels. This increase in intracellular calcium ion concentration induces the secretion of insulin. It is used for the concomitant use with insulin for the treatment of noninsulin-dependent (type 2) diabetes mellitus.

Struktur Molekul 2D

Berat 309.341
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) 4 hours.
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Rapidly and completely absorbed following oral administration.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

621 Data
Pegvisomant The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Glymidine.
Nicotine The risk or severity of adverse effects can be increased when Glymidine is combined with Nicotine.
Mecamylamine The risk or severity of adverse effects can be increased when Glymidine is combined with Mecamylamine.
Pentolinium The risk or severity of adverse effects can be increased when Glymidine is combined with Pentolinium.
Trimethaphan The risk or severity of adverse effects can be increased when Glymidine is combined with Trimethaphan.
Hexamethonium The risk or severity of adverse effects can be increased when Glymidine is combined with Hexamethonium.
Cyclopentamine The risk or severity of adverse effects can be increased when Glymidine is combined with Cyclopentamine.
Methotrexate The protein binding of Methotrexate can be increased when combined with Glymidine.
Lipoic acid The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Glymidine.
Moxifloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Moxifloxacin.
Grepafloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Grepafloxacin.
Enoxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Enoxacin.
Pefloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Pefloxacin.
Ciprofloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Ciprofloxacin.
Trovafloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Trovafloxacin.
Nalidixic acid The therapeutic efficacy of Glymidine can be increased when used in combination with Nalidixic acid.
Rosoxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Rosoxacin.
Cinoxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Cinoxacin.
Lomefloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Lomefloxacin.
Gatifloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Gatifloxacin.
Norfloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Norfloxacin.
Levofloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Levofloxacin.
Gemifloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Gemifloxacin.
Ofloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Ofloxacin.
Sparfloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Sparfloxacin.
Temafloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Temafloxacin.
Fleroxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Fleroxacin.
Technetium Tc-99m ciprofloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Technetium Tc-99m ciprofloxacin.
Garenoxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Garenoxacin.
Nemonoxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Nemonoxacin.
Flumequine The therapeutic efficacy of Glymidine can be increased when used in combination with Flumequine.
Enrofloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Enrofloxacin.
Orbifloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Orbifloxacin.
Sarafloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Sarafloxacin.
Difloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Difloxacin.
Pazufloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Pazufloxacin.
Prulifloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Prulifloxacin.
Delafloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Delafloxacin.
Sitafloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Sitafloxacin.
Oxolinic acid The therapeutic efficacy of Glymidine can be increased when used in combination with Oxolinic acid.
Rufloxacin The therapeutic efficacy of Glymidine can be increased when used in combination with Rufloxacin.
Pipemidic acid The therapeutic efficacy of Glymidine can be increased when used in combination with Pipemidic acid.
Methyclothiazide The therapeutic efficacy of Glymidine can be decreased when used in combination with Methyclothiazide.
Chlorthalidone The therapeutic efficacy of Glymidine can be decreased when used in combination with Chlorthalidone.
Bendroflumethiazide The therapeutic efficacy of Glymidine can be decreased when used in combination with Bendroflumethiazide.
Metolazone The therapeutic efficacy of Glymidine can be decreased when used in combination with Metolazone.
Benzthiazide The therapeutic efficacy of Glymidine can be decreased when used in combination with Benzthiazide.
Hydroflumethiazide The therapeutic efficacy of Glymidine can be decreased when used in combination with Hydroflumethiazide.
Indapamide The therapeutic efficacy of Glymidine can be decreased when used in combination with Indapamide.
Chlorothiazide The therapeutic efficacy of Glymidine can be decreased when used in combination with Chlorothiazide.
Hydrochlorothiazide The therapeutic efficacy of Glymidine can be decreased when used in combination with Hydrochlorothiazide.
Trichlormethiazide The therapeutic efficacy of Glymidine can be decreased when used in combination with Trichlormethiazide.
Polythiazide The therapeutic efficacy of Glymidine can be decreased when used in combination with Polythiazide.
Quinethazone The therapeutic efficacy of Glymidine can be decreased when used in combination with Quinethazone.
Cyclopenthiazide The therapeutic efficacy of Glymidine can be decreased when used in combination with Cyclopenthiazide.
Epitizide The therapeutic efficacy of Glymidine can be decreased when used in combination with Epitizide.
Amitriptyline Amitriptyline may decrease the hypoglycemic activities of Glymidine.
Protriptyline Protriptyline may decrease the hypoglycemic activities of Glymidine.
Imipramine Imipramine may decrease the hypoglycemic activities of Glymidine.
Nortriptyline Nortriptyline may decrease the hypoglycemic activities of Glymidine.
Amoxapine Amoxapine may decrease the hypoglycemic activities of Glymidine.
Trimipramine Trimipramine may decrease the hypoglycemic activities of Glymidine.
Doxepin Doxepin may decrease the hypoglycemic activities of Glymidine.
Desipramine Desipramine may decrease the hypoglycemic activities of Glymidine.
Clomipramine Clomipramine may decrease the hypoglycemic activities of Glymidine.
Amineptine Amineptine may decrease the hypoglycemic activities of Glymidine.
Dimetacrine Dimetacrine may decrease the hypoglycemic activities of Glymidine.
Butriptyline Butriptyline may decrease the hypoglycemic activities of Glymidine.
Dosulepin Dosulepin may decrease the hypoglycemic activities of Glymidine.
Tianeptine Tianeptine may decrease the hypoglycemic activities of Glymidine.
Oxaprotiline Oxaprotiline may decrease the hypoglycemic activities of Glymidine.
Opipramol Opipramol may decrease the hypoglycemic activities of Glymidine.
Amitriptylinoxide Amitriptylinoxide may decrease the hypoglycemic activities of Glymidine.
Dibenzepin Dibenzepin may decrease the hypoglycemic activities of Glymidine.
Quinupramine Quinupramine may decrease the hypoglycemic activities of Glymidine.
Melitracen Melitracen may decrease the hypoglycemic activities of Glymidine.
Lofepramine Lofepramine may decrease the hypoglycemic activities of Glymidine.
Iprindole Iprindole may decrease the hypoglycemic activities of Glymidine.
Imipramine oxide Imipramine oxide may decrease the hypoglycemic activities of Glymidine.
Ketoprofen The risk or severity of adverse effects can be increased when Ketoprofen is combined with Glymidine.
Dexketoprofen The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Glymidine.
Cyclosporine The risk or severity of renal failure can be increased when Glymidine is combined with Cyclosporine.
Dapagliflozin Dapagliflozin may increase the hypoglycemic activities of Glymidine.
Canagliflozin Canagliflozin may increase the hypoglycemic activities of Glymidine.
Leuprolide The therapeutic efficacy of Glymidine can be decreased when used in combination with Leuprolide.
Goserelin The therapeutic efficacy of Glymidine can be decreased when used in combination with Goserelin.
Nelfinavir The therapeutic efficacy of Glymidine can be decreased when used in combination with Nelfinavir.
Indinavir The therapeutic efficacy of Glymidine can be decreased when used in combination with Indinavir.
Ziprasidone The therapeutic efficacy of Glymidine can be decreased when used in combination with Ziprasidone.
Etonogestrel The therapeutic efficacy of Glymidine can be decreased when used in combination with Etonogestrel.
Desogestrel The therapeutic efficacy of Glymidine can be decreased when used in combination with Desogestrel.
Olanzapine The therapeutic efficacy of Glymidine can be decreased when used in combination with Olanzapine.
Megestrol acetate The therapeutic efficacy of Glymidine can be decreased when used in combination with Megestrol acetate.
Clozapine The therapeutic efficacy of Glymidine can be decreased when used in combination with Clozapine.
Levonorgestrel The therapeutic efficacy of Glymidine can be decreased when used in combination with Levonorgestrel.
Progesterone The therapeutic efficacy of Glymidine can be decreased when used in combination with Progesterone.
Chlorpromazine The therapeutic efficacy of Glymidine can be decreased when used in combination with Chlorpromazine.
Haloperidol The therapeutic efficacy of Glymidine can be decreased when used in combination with Haloperidol.
Ritonavir The therapeutic efficacy of Glymidine can be decreased when used in combination with Ritonavir.
Piperazine The therapeutic efficacy of Glymidine can be decreased when used in combination with Piperazine.

Target Protein

ATP-sensitive inward rectifier potassium channel 1 KCNJ1
ATP-sensitive inward rectifier potassium channel 10 KCNJ10
ATP-binding cassette sub-family C member 8 ABCC8

Referensi & Sumber

Synthesis reference: U.S. Patent 3,275,635.

Contoh Produk & Brand

Produk: 0 • International brands: 5
International Brands
  • Glycanol — Bayer
  • Glyconormal — Bayer
  • Gondafon — Schering
  • Lycanol — Bayer
  • Redul — Bayer

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul